Freedom of Information Team
Department of Health and Social Care
39 Victoria Street
London SW1H 0EU
Ms Louise Bicknell
By email to: email@example.com
23 December 2022
Dear Ms Bicknell, Freedom of Information Request Reference FOI-1428124
Thank you for your request dated 29 November to the Department of Health and Social
Care (DHSC), a copy of which can be found in the accompanying annex.
Your request has been handled under the Freedom of Information Act 2000 (FOIA).
DHSC holds information relevant to your request.
Please find attached four two email chains, a Teams meeting invitation and a meeting
Please note that some of this information has been redacted under section 40(2) of the
FOIA, which provides for the protection of personal information. Section 40 prohibits a
public body from disclosing personally identifiable information, as doing so would
contravene data protection principles.
If you are not satisfied with the handling of your request, you have the right to appeal by
asking for an internal review. This should be sent to firstname.lastname@example.org
to the address at the top of this letter and be submitted within two months of the date of
Please remember to quote the reference number above in any future communication.
If you are not content with the outcome of your internal review, you may complain directly
to the Information Commissioner’s Office (ICO). Generally, the ICO cannot make a
decision unless you have already appealed our original response and received our internal
review decision. You should raise your concerns with the ICO within three months of your
last meaningful contact with us.
Guidance on contacting the ICO can be found at https://ico.org.uk/global/contact-us
information about making a complaint can be found at https://ico.org.uk/make-a-complaint.
Freedom of Information Team email@example.com
From: Louise Bicknell firstname.lastname@example.org
Sent: 29 November 2022 16:12
To: FreedomofInformation email@example.com
Subject: Freedom of Information request - Communications on Evusheld between
Professor James Palmer and Charlotte Taylor of the Antivirals and Therapeutics Taskforce
Dear Department of Health and Social Care,
For the period 1 April 2022 to 6 September 2022
All direct communications between Professor James Palmer with Charlotte Taylor of the
Antivirals and Therapeutics Taskforce in which Evusheld (i.e. the combination of
Tixagevimab and cilgavimab, AZD7742 or any other name that is used by the DHSC for
this) is mentioned, whether by email or other electronic means.
Please use this email address for all replies to this request: